Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma [2]

Chest

Volumn 123, Issue 6, 2003, Pages 2155-2156

  Passero, Michael ^a,b   Chowdhry, Sapna ^a   Hinojosa, Miguel ^c   Martín Garcia, Cristina ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hospital Ramon y Cajal ^*  (United States)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; ROFECOXIB; SALBUTAMOL;

AGED; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CASE REPORT; DISEASE EXACERBATION; DRUG SAFETY; ENZYME INHIBITION; FEMALE; HUMAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0037709666     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.6.2155     Document Type: Letter

References (4)

1. C Martin-Garcia M Hinojosa P Berges Safety of aécyclooxygenase-2 inhibitor in patients with aspirin-sensitiveéasthma Chest 121 2002 1812 1817
2. A Szczeklik E Nizankowska G Bochenek Safety of aéspecific COX-2 inhibitor in aspirin-induced asthma Clin ExpéAllergy 31 2001 219 225
3. DD Stevenson RA Simon Lack of cross-reactivity betweenérofecoxib and aspirin in aspirin-sensitive patients with asthma J Allergy Clin Immunol 108 2001 47 51
4. B Dahlen A Szczeklik JJ Murray Celecoxib in patients withéasthma and aspirin intolerance [letter] N Engl J Med 344 2001 142